73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Cancer risk found to be higher in asthma patients

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.
As patients live longer, new criteria needed for prostate cancer trials

As patients live longer, new criteria needed for prostate cancer trials

JANUARY 26, 2024by Olivia Dimmer,Northwestern UniversityKaplan-Meier curves for (A) OS and rPFS and (B) OS and cPFS. cPFS=clinical progression-free survival; OS=overall survival; rPFS=radiograph

As patients live longer, new criteria needed for prostate cancer trials

JANUARY 26, 2024by Olivia Dimmer,Northwestern UniversityKaplan-Meier curves for (A) OS and rPFS and (B) OS and cPFS. cPFS=clinical progression-free survival; OS=overall survival; rPFS=radiograph
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
Possible therapeutic approach to fight incurable blood cancer

Possible therapeutic approach to fight incurable blood cancer

by Technical University MunichGraphical abstract. Credit:The EMBO Journal(2022). DOI: 10.15252/embj.2022110871Multiple myeloma (MM) is the second most common type of blood cancer. It

Possible therapeutic approach to fight incurable blood cancer

by Technical University MunichGraphical abstract. Credit:The EMBO Journal(2022). DOI: 10.15252/embj.2022110871Multiple myeloma (MM) is the second most common type of blood cancer. It
More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobili

More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobili
Researchers discover a weakness in a rare cancer that could be exploited with drugs

Researchers discover a weakness in a rare cancer that could be exploited with drugs

by Rockefeller UniversitySome cancer cells cannot produce cholesterol, and instead build up an excess of squalene (pink)--a molecule that may help these dangerous cells thrive. Credit: Laboratory

Researchers discover a weakness in a rare cancer that could be exploited with drugs

by Rockefeller UniversitySome cancer cells cannot produce cholesterol, and instead build up an excess of squalene (pink)--a molecule that may help these dangerous cells thrive. Credit: Laboratory
Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva
Less invasive for patients: Using blood tests to diagnose lung cancer

Less invasive for patients: Using blood tests to diagnose lung cancer

by Eindhoven University of TechnologyCredit: Pixabay/CC0 Public DomainCurrently, when lung cancer is suspected, a "morsel" of tissue is removed and examined under the microscope. This m

Less invasive for patients: Using blood tests to diagnose lung cancer

by Eindhoven University of TechnologyCredit: Pixabay/CC0 Public DomainCurrently, when lung cancer is suspected, a "morsel" of tissue is removed and examined under the microscope. This m
Aggressive breast cancers store large amounts of energy, which enables it to spread: study

Aggressive breast cancers store large amounts of energy, which enables it to spread: study

by University of MichiganSofia Merajver, M.D., Ph.D. Credit: University of Michigan Rogel Cancer CenterCancer cells—especially the more aggressive ones—seem to have an ability to change. It's

Aggressive breast cancers store large amounts of energy, which enables it to spread: study

by University of MichiganSofia Merajver, M.D., Ph.D. Credit: University of Michigan Rogel Cancer CenterCancer cells—especially the more aggressive ones—seem to have an ability to change. It's
A blood test for colon cancer performed well in a study, expanding options for screening

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs
High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes
Drug shows promise as immune therapy for cancer

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese